PK

Pawan Kumar Hanumanth

Active Director Director DIN 06407279
DIN 06407279 First appointment Nov 2012 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2012
Shareholding value •••• Premium profile

About Pawan Kumar Hanumanth

Data last updated:

Pawan Kumar Hanumanth is a Director at Acara Bioherb Private Limited (since 2012). The company operates in Healthcare. Acara Bioherb Private Limited reported revenue of ₹2.85 Cr (FY 2023).

DIN 06407279
Primary Designation Director
Industry Healthcare
First Appointment 16 Nov 2012
Oldest Company Age 14 yrs
Largest company Acara Bioherb Private Limited · ₹2.85 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Acara Bioherb Private Limited U24233KA2012PTC066776
Director16 Nov 20122012₹2.85 Cr (FY 2023)Active

Board colleagues of Pawan Kumar Hanumanth

Directorship timeline

Open interactive timeline →
Acara Bioherb Private Limited
Premium access

Shareholding and investment profile for Pawan Kumar Hanumanth

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pawan Kumar Hanumanth

Pawan Kumar Hanumanth currently holds 1 directorship: Acara Bioherb Private Limited (Director, since 16 Nov 2012, revenue ₹2.85 Cr (FY 2023)).

Pawan Kumar Hanumanth was first appointed on 16 Nov 2012 as Director at Acara Bioherb Private Limited.

The current boards of Pawan Kumar Hanumanth's companies include Holenarsipur Rangappahanumantha Kumar (Acara Bioherb Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available